Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grail Inc
NASDAQ:GRAL
|
US |
Grail is a healthcare diagnostics company that develops blood tests for finding cancer signals early, before symptoms appear. Its best-known product is a multi-cancer early detection test that analyzes fragments of DNA in a blood sample to look for signs of cancer and, in some cases, suggest where in the body the signal may be coming from.
The company sells these tests to doctors, health systems, employers, and, in some cases, consumers through medical channels. Grail makes money mainly by selling tests and by building clinical evidence and testing programs that can be used in screening and preventive care. Its business sits between traditional lab testing and oncology: it is not treating cancer, but trying to change how cancer is found in the first place.
What makes Grail different is that it is focused on a new category of screening rather than a standard lab menu. Its value depends on getting doctors, payers, and health systems to trust that a blood test can help catch hard-to-detect cancers earlier and fit into routine care.
© 2026 Alpha Spread Limited. All Rights Reserved.
www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more